Pancreatic Cancer Therapeutics and Diagnostics Market Share, Growth, Size, Trends & Forecast 2023-2028
IMARC Group, a leading market research company, has recently released a report titled “Pancreatic Cancer Therapeutics and Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”. The study provides a detailed analysis of the industry, including the pancreatic cancer therapeutics and diagnostics market share, size, trends and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the Pancreatic Cancer Therapeutics and Diagnostics Market?
The global pancreatic cancer therapeutics and diagnostics market size reached US$ 3.96 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.08 Billion by 2028, exhibiting a growth rate (CAGR) of 7.46% during 2023-2028.
What is Pancreatic Cancer Therapeutics and Diagnostics?
Pancreatic cancer therapeutics and diagnostics encompass a range of medical procedures employed for the diagnosis and treatment of pancreatic cancer. They include ultrasound, computerized tomography (CT) scans, positron emission tomography (PET) scans, and magnetic resonance imaging (MRI). These pancreatic cancer therapeutics and diagnostics methods aid in monitoring the tumor's location and detecting abnormal cell growth in the pancreas. They facilitate the performance of biopsies, which involve the removal of a small tissue sample for microscopic examination. Pancreatic cancer therapeutics and diagnostics even aid in laboratory investigations, such as complete blood count (CBC), liver enzyme tests to assess biliary obstruction, and fasting glucose and glycated hemoglobin (HbA1C) tests. Consequently, they find widespread applications in hospitals and specialized centers across the globe.
What are the growth prospects and trends in the pancreatic cancer therapeutics and diagnostics industry?
Pancreatic cancer therapeutics and diagnostics market is primarily driven by the expanding elderly population and the elevating emphasis on advancing molecular biology, drugs, and diagnostic technology. Besides this, the growing healthcare industry and the escalating need for chemotherapy to control the growth and division of pancreatic cancer cells are also positively influencing the market growth. Moreover, the inflating investments by government bodies across numerous countries in clinical trials for pancreatic cancer and exploring the use of DNA repair inhibitors in combination with chemotherapy are acting as significant growth-inducing factors. Apart from this, the introduction of humanized monoclonal antibodies by leading market players that stimulate the anti-tumor immune response for targeting esophageal, gastroesophageal junction, and pancreatic cancer and the development of kit-based testing methods to detect pancreatic cancer through evaluation of genomic instability and identification of BRCA1 and BRCA2 variants are expected to bolster the pancreatic cancer therapeutics and diagnostics market in the coming years.
What is included in market segmentation?
The report has segmented the market into the following categories:
Type Insights:
Diagnostics
Imaging
Biopsy
Endoscopic Ultrasound
Others
Treatment
Targeted Therapies
Chemotherapy
Surgery
Others
Application Insights:
Hospitals
Clinics
Others
Market Breakup by Region:
North America (United States, Canada)
Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
AstraZeneca plc
F. Hoffmann-La Roche Ltd.
Immunovia AB
Novartis AG
Pfizer Inc.
Ask an Analyst : https://www.imarcgroup.com/request?type=report&id=7538&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
